Non-Interventional Study to Capture the Patient Experience on Gene Therapy for Hemophilia Within the AskBio009-101 Study Through Patient and Investigator Interviews

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03054389

Enrollment

Registered

2017-02-15

Start date

2017-03-31

Completion date

2017-06-06

Last updated

2021-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemophilia B

Brief summary

The purpose of this study is to seek to understand the patient's perspective around deciding to participate in a clinical trial for a Hemophilia therapy

Interventions

OTHERQualitative Interview - Participants/ Patients

Qualitative interviews to understand the patient experience with the AskBio009-101 Study - Participants/ Patients

OTHERQualitative Interview - Investigators and Study Coordinators

Qualitative interviews to understand the patient experience with the AskBio009-101 Study - Investigators and Study Coordinators

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

for patients: * Were screened and consented for the AskBio009-101study at any point in time * Are able to speak and understand English * Are between ages of 18 and 75 * Are physically able to participate in a one-hour phone interview * Consented into this study independently of the AskBio009-101 study

Exclusion criteria

for patients: \- N/A Inclusion criteria for investigators and coordinators: * Worked at a site as an investigator or study coordinator that consented a patient into the * AskBio009-101 trial at any point in time, including those that no longer work at a AskBio009-101 site * Are able to speak and understand English * Are between ages of 18 and 75 * Are physically able to participate in a one-hour phone interview

Design outcomes

Primary

Measure	Time frame	Description
Interview - AskBio009-101 Study - Participants/ Patients	Approximately 1 hour	Qualitative telephone interviews to understand the patient experience with the AskBio009-101 Study - Participant/ Patient Interview
Interview - AskBio009-101 Study - Investigators and Study Coordinators	Approximately 1 hour	Qualitative telephone interviews to understand the patient experience with the AskBio009-101 Study - Investigators and Study Coordinators Interview

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026